2004 Barriers of CNS

2004 中枢神经系统障碍

• 批准号: 6836684
• 负责人: Martha E O'Donnell
• 金额: $ 1万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-06-01 至 2005-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6836684
• 关键词: blood brain barrier; central nervous system; drug delivery systems; gene therapy; meeting /conference /symposium

DESCRIPTION (provided by applicant): This proposal is a request for funds toward support of the 3rd "Barriers of the CNS" Gordon Research Conference to be held June 27th to July 2nd 2004 in Tilton, NH. Funds are also requested for support of the 4th and 5th conferences, to be held in 2006 and 2008. This Gordon Research Conference was initiated as a catalyst for interaction among researchers from a variety of disciplines working on issues of blood-brain-barrier (BBB) and blood-CSF barrier in health and disease. Research in this area is already leading to development of new therapeutic approaches for the treatment of stroke, head trauma, neurodegeneration, brain inflammation and brain tumors, to name a few. Although portions of these areas of investigation are represented at several national and international research meetings, there have been few opportunities for scientists working in the field to come together with a specific concentrated focus on issues related to barriers of the CNS. The upcoming 2004 conference will include issues related to the physiology and pathophysiology of the BBB and blood-CSF barriers as well as the delivery of drug and gene therapies to the CNS. A new aspect of the 2004 meeting will be consideration of the neurovascular unit and how BBB cells interact with other cells in the neural environment. It is especially noteworthy that blood-brain barrier research has been identified by NIH as a critical area for development. Consistent with this, the mission of the Barriers of the CNS Gordon Research Conferences is to provide a forum for scientists with a variety of backgrounds and experience to share unpublished findings and work together to identify new strategies for attacking the many remaining unanswered questions with respect to the BBB and blood/CSF barriers. To this end, eminent scientists from both academia and the pharmaceutical industry are being brought together for an exciting "leading edge" meeting. Speakers have been selected on the basis of their eminence in the field and their communication skills. They are drawn from a wide geographical background. Chairs of the sessions have been selected on the basis of their considerable eminence and experience in the field and a known ability to communicate and debate well. In addition the presentation of posters is being vigorously encouraged especially by young postdoctoral and research students. It is expected that a considerable proportion of any NIH grant will be used to fund the attendance of young scientists and chairs. Two open workshops/debates to occur during the meeting are also planned. The maximum permitted attendance at this meeting is 150 scientists.

描述（由申请人提供）：该提案是为支持2004年6月27日至2004年7月2日在新罕布什尔州蒂尔顿举行的第三次“ CNS”戈登研究会议的资金请求。 还要求资金支持2006年和2008年举行的第四和第五会议。该戈登研究会议是为了在健康和疾病中从事血脑屏障问题（BBB）和血液-CSF障碍问题的各种学科研究人员之间互动的催化剂。 该领域的研究已经导致开发新的治疗方法，用于治疗中风，头部创伤，神经退行性，脑部炎症和脑肿瘤，仅举几例。 尽管在几次国家和国际研究会议上代表了这些调查领域的一部分，但在该领域工作的科学家很少有机会将其集中在与中枢神经系统障碍有关的问题上。 即将举行的2004年会议将包括与BBB和血液-CSF障碍的生理学和病理生理学有关的问题，以及向CNS提供药物和基因疗法的问题。 2004年会议的一个新方面将考虑神经血管单元，以及BBB细胞如何在神经环境中与其他细胞相互作用。 尤其值得注意的是，NIH已将血脑屏障研究确定为开发的关键领域。 与此一致，中枢神经系统戈登研究会议的障碍的使命是为具有多种背景和经验的科学家提供一个论坛，以分享未发表的发现，并共同努力，以确定攻击许多关于BBB和血液/CSF障碍的剩余未解决问题的新策略。 为此，来自学术界和制药行业的著名科学家都聚集在一起，参加激动人心的“领先”会议。 演讲者是根据他们在该领域的杰出及其沟通技巧的基础选择的。 它们来自广泛的地理背景。 会议主席是根据其在该领域的杰出和经验以及已知的沟通和辩论能力的基础上选择的。 此外，特别是由年轻的博士后和研究专业的学生强烈鼓励海报的介绍。 预计任何NIH赠款中有相当一部分将用于资助年轻科学家和椅子的出席。 还计划在会议期间举行两个开放的研讨会/辩论。 在这次会议上的最大允许出勤率是150位科学家。